PREVIOUS
✖
Cancer Biomarker Tests
November 14 , 2025
15 hrs 0 min
9
0
- Servier India launched an affordable biomarker testing initiative for leukaemia and bile duct cancer.
- The initiative was started with Med Genome and Strand Life Sciences to improve access to molecular testing.
- It focused on Acute Myeloid Leukaemia (AML) and Cholangiocarcinoma (CCA) with subsidised tests across India.
- Free Isocitrate Dehydrogenase 1 (IDH1) and Isocitrate Dehydrogenase 2 (IDH2) mutation testing was offered for the government sector.
- The initiative aimed to support early diagnosis and expand precision cancer care.
Leave a Reply
Your Comment is awaiting moderation.